Article Top Ad
Reading Time: < 1 minute

Nano Shot product debuts new Fuse(TM) brand; employs Emerald’s science-based innovation to provide rapid onset and more predictable, shorter-duration effects

Vancouver, British Columbia–(Newsfile Corp. – July 21, 2021) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) (“Emerald”) has introduced its new Fuse™ lifestyle brand and latest product line, the Nano Shot, a flavoured cannabis-infused beverage formulated with 10 mg of THC and a nanoemulsion formulation that assures consumers of a more predictable, rapid onset and shorter controlled duration of effects. Initial shipments of the beverage are available to consumers at licensed cannabis retailers and online in British Columbia and Manitoba, and are expected to be available in Alberta by month-end. They are also available to patients with prescriptions via Emerald’s Direct to Health medical e-commerce site.

To view the source version of this press release, please visit

Powered by WPeMatico